ES2105970B1 - Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas. - Google Patents
Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas.Info
- Publication number
- ES2105970B1 ES2105970B1 ES9501566A ES9501566A ES2105970B1 ES 2105970 B1 ES2105970 B1 ES 2105970B1 ES 9501566 A ES9501566 A ES 9501566A ES 9501566 A ES9501566 A ES 9501566A ES 2105970 B1 ES2105970 B1 ES 2105970B1
- Authority
- ES
- Spain
- Prior art keywords
- ciprofloxacino
- stable
- aqueous
- pharmaceutical composition
- oral pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical group C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008203 oral pharmaceutical composition Substances 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- -1 ACIDS TRIGLYCERIDES Chemical class 0.000 abstract 1
- 235000009470 Theobroma cacao Nutrition 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 244000240602 cacao Species 0.000 abstract 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 abstract 1
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 abstract 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 abstract 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 abstract 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 239000002562 thickening agent Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSICION FARMACEUTICA ORAL DE CLOROFLOXACINO NO ACUOSA. ESTABLE Y CON CARACTERISTICAS ORGANOLEPTICAS MEJORADAS. POR CADA 100 ML, COMPRENDE: ENTRE 5 Y 15 G DE CIPROFLOXACINO; ENTRE 0.01 Y 0.3 G DE CONSERVANTES SELECCIONADOS ENTRE EL GRUPO FORMADO POR P-HIDROXIBENZOATO DE METILO, P-HIDROXIBENZOATO DE ETILO, P-HIDROXIBENZOATO DE PROPILO, BUTILHIDROXIANISOL, BUTILHIDROXITOLUENO, ACIDO SORBICO Y SUS MEZCLAS; ENTRE 5 Y 20 G DE POLVO DE CACAO; Y EL RESTO ES UN VEHICULO OLEOSO COMESTIBLE FORMADO POR TRIGLICERIDOS DE ACIDOS DE CADENA CORTA O MEDIA, PREFERIBLEMENTE DE ACIDO CAPRILICO, CAPRICO Y SUS MEZCLAS. REALIZACIONES PREFERIDAS CONTIENEN ADEMAS ENTRE 0.01 Y 1 G DE UN ESPESANTE, UNA CANTIDAD EFECTIVA DE UN EDULCORANTE, Y UNA CANTIDAD EFECTIVA DE UN AROMATIZANTE. TIENE UTILIDAD PARA LA ADMINISTRACION DE CIPROFLOXACINO, ESPECIALMENTE CON NIÑOS Y ANCIANOS, RESULTANDO MUCHO MAS ESTABLE Y AGRADABLE QUE LAS SUSPENSIONES ACUOSAS CONOCIDAS.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9501566A ES2105970B1 (es) | 1995-08-02 | 1995-08-02 | Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9501566A ES2105970B1 (es) | 1995-08-02 | 1995-08-02 | Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2105970A1 ES2105970A1 (es) | 1997-10-16 |
| ES2105970B1 true ES2105970B1 (es) | 1998-07-01 |
Family
ID=8291260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES9501566A Expired - Lifetime ES2105970B1 (es) | 1995-08-02 | 1995-08-02 | Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas. |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES2105970B1 (es) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000076549A1 (es) * | 1999-06-10 | 2000-12-21 | Laboratorios S.A.L.V.A.T., S.A. | Composicion farmaceutica liquida para la administracion oral de principios activos amargos y susceptibles de hidrolisis |
| US6261601B1 (en) | 1997-09-19 | 2001-07-17 | Ranbaxy Laboratories Limited | Orally administered controlled drug delivery system providing temporal and spatial control |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2160090B1 (es) * | 2000-03-16 | 2002-07-01 | Vita Invest Sa | Composiciones acuosas de ciprofloxacino, contenidas en envases monodosis y su utilizacion. |
| SE0202365D0 (sv) * | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
| ES2934136T3 (es) * | 2016-09-21 | 2023-02-17 | Lts Lohmann Therapie Systeme Ag | Forma de dosificación oral |
| US12285488B2 (en) | 2018-03-01 | 2025-04-29 | Lts Lohmann Therapie-Systeme Ag | Oral dosage form containing theobromine-free cocoa |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
| CA1285279C (en) * | 1984-02-17 | 1991-06-25 | Joseph P. Sanchez | 7-amine derivatives of 1-cyclopropyl-6,8-difluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acids and 1-cyclopropyl-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine- 3-carboxylic acidsas antibacterial agents |
-
1995
- 1995-08-02 ES ES9501566A patent/ES2105970B1/es not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6261601B1 (en) | 1997-09-19 | 2001-07-17 | Ranbaxy Laboratories Limited | Orally administered controlled drug delivery system providing temporal and spatial control |
| US6960356B1 (en) | 1997-09-19 | 2005-11-01 | Ranbaxy Laboratories Limited | Orally administered drug delivery system providing temporal and spatial control |
| WO2000076549A1 (es) * | 1999-06-10 | 2000-12-21 | Laboratorios S.A.L.V.A.T., S.A. | Composicion farmaceutica liquida para la administracion oral de principios activos amargos y susceptibles de hidrolisis |
| ES2153786A1 (es) * | 1999-06-10 | 2001-03-01 | S A L V A T Lab Sa | Composicion farmaceutica liquida para la administracion oral de principios activos amargos y susceptibles de hidrolisis. |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2105970A1 (es) | 1997-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR005593A1 (es) | Producto masticable confitado con centro de goma de mascar y cobertura y metodo de preparacion | |
| FI915387A7 (fi) | Purukumi, joka luovuttaa makua pidennetyn ajanjakson aikana ja joka sisältää tyydyttämättömiä, puhdistettuja monoglyserideja | |
| AU7134200A (en) | Method of encapsulating flavors and fragrances by controlled water transport into microcapsules | |
| CA2304556A1 (en) | Method of encapsulated flavors and fragrances by controlled water transport into microcapsules | |
| MA26537A1 (fr) | Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant. | |
| CA2292673A1 (en) | Pharmaceutical compositions containing eletriptan hemisulphate | |
| DE69821115T2 (de) | Gefüllter konfekt | |
| FR2822826B1 (fr) | Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ES8801766A1 (es) | Procedimiento de obtencion de un sistema de suministro de ingredientes activos | |
| IT8019276A0 (it) | N-benzil-immidazoli come inibitori selettivi dell'enzima trombossano sintetasi, loro composizioni farmaceutiche e procedimento per la loro preparazione. | |
| RU94045815A (ru) | Водная взвесь жидких капсул ароматического масла, способ ее получения и способ приготовления пищевых продуктов с использованием этого вещества | |
| PT754407E (pt) | Formulacoes liquidas de 1,2-benzisotiazolin-3-ona | |
| IT1248588B (it) | Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari. | |
| ES2105970B1 (es) | Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas. | |
| DE68915163D1 (de) | Emulgiermittel zur verlängerung des geschmacks bei kaugummi. | |
| EA200000192A1 (ru) | Композиции с усиленным ароматом, содержащие n-этил-п-ментан-3-карбоксамид, и способ их получения и применения | |
| PH24395A (en) | Sweet emulsion for chewing gum | |
| NO982754D0 (no) | Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter | |
| ZA965893B (en) | Flavouring of edible oils. | |
| AU6571400A (en) | Pharmaceutical formulation comprising amoxycillin and clavulanate | |
| FR2599039B1 (fr) | Nouvelle substance immuno-suppressive, sa preparation par culture de streptomyces sp. (cbs 162.86) et les compositions pharmaceutiques qui la contiennent | |
| ZA975755B (en) | Useful formulations of acid addition salt drugs. | |
| ES547855A0 (es) | Procedimiento para la preparacion de nuevas sales fisiologi-camente activas o aceptables de sabor dulce | |
| MA26579A1 (fr) | Nouveaux derives de la vitamine "d" | |
| IT8720019A0 (it) | Processo per la sintesi dell'alfa-(1-metiletil)-3,4-dimetossibenzeneacetonitrile. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19971016 Kind code of ref document: A1 Effective date: 19971016 |